Westaim announces 2007 year-end results (Months Ended Twelve Months Ended ...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

Westaim announces 2007 year-end results

Date:2/15/2008

Months Ended Twelve Months Ended

December 31 December 31

--------------------- ---------------------

Segmented Information 2007 2006 2007 2006

-------------------------------------------------------------------------

Revenue from continuing

operations

Nucryst Pharmaceuticals $ 11,174 $ 5,140 $ 31,830 $ 27,591

-------------------------------------------------------------------------

Operating income (loss)

Nucryst Pharmaceuticals $ 3,532 $ (2,200) $ (635) $ (11,216)

Other (including

corporate costs) (1,826) (1,311) (10,805) (6,128)

-------------------------------------------------------------------------

Operating income (loss) from

continuing operations $ 1,706 $ (3,511) $ (11,440) $ (17,344)

-------------------------------------------------------------------------

December December

Consolidated Balance Sheets 31, 2007 31, 2006

---------------------------------------------------

Cash and short-term

investments $ 30,993 $ 62,486

Current assets 51,561 80,256

Other assets 31,826 68,083

Current liabilities 8,461 15,977

Shareholders' equity 56,371 112,977

THE WESTAIM CORPORATION

Consolidated Statements of Operations and Consolidated Statements

of Comprehensive loss and Deficit

(unaudited)

-------------------------------------------------------------------------

Three Mont
'/>"/>

SOURCE Westaim Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12
Related medicine news :

1. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Fourth Quarter Results
2. Westaim reduces ABCP exposure
3. Westaim announces 2007 third quarter results
4. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Third Quarter Results
5. The Westaim Corporation update on status of short-term investments
6. Abbott Announces 10.8 Percent Increase in Quarterly Dividend
7. China Holdings Announces Starwood Research Institute Initiates Research Coverage
8. Lieff Cabraser Heimann & Bernstein, LLP Announces Class Action Lawsuits Have Been Filed Against American Dental Partners, Inc.
9. Hillenbrand Announces Mailing of Proxy Regarding Changing of Company Name in Conjunction with Planned Separation
10. Nerites Corporation Announces Closing of Series A Funding Round
11. Concentric Medical Names Kimberly Bridges as Vice President of Sales, Announces Receipt of $15 Million Growth Funding

Post Your Comments:

(Date:12/5/2009)NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual Meeting of the American Society of Hematology int

(Date:12/5/2009)Midbrook,s advanced Technology Center helps companies develop and test their cleaning processes. The technology available to the lab allows it to work in a variety of industries and solve problems for

(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W

(Date:12/4/2009)NEW YORK, Dec. 4 Thousands of KPMG LLP employees came together in more than 90 offices nationwide today, to participate in a community service event which combines the audit, tax and advisory firm,s

(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i

[0] Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders [0] Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification [0] Distributor Announces New Applications for Wind Turbines [0] KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children [0] Statement from AAHSA CEO Larry Minnix on the Failure of the Thune Amendment

...procedures are generally being fleased from patien...ne of California, observed a study at present whic...sary fertility procedures.// Lawrence Werlin,...gnosis (PGD) for three distinct groups of women. P...

...n pointed at reducing carbon monoxide emissions ha...onoxide can be fatal if inhaled and is involved in...ear. //The main sources of carbon monoxide are veh...talytic converters in cars helps bring down the ca...

...to researchers, it may be possible to increase the...shortage of organs for transplantation.// Research...ng at the supply of lungs for transplant. They not...hecked 30 pairs of lungs that had been rejected fo...

...to researchers in England, a baby's birth weight i...late adulthood. The study also shows women with th...risk of developing diabetes.// More than 4,10...ing among those with the highest insulin resistanc...

...rs at the Colulmbia University found that eating m...eloping Alzheimer's disease in some people. Previo...ricted diet tend to live longer. //Researchers fee...lso damage cells and may increase the damage done ...

...antioxidants have always been beneficial to our bo...tent is released from the grain, and thereby makin...e has always been a common misconception that boil...ou may well gain more antioxidant power than you l...

Other Medicine News:Health News:Diet combined to Alzheimer's disease 2

Benefits in fertility procedures Carbon monoxide passes down Time to re-assess lung donation concept Link between birth weight and Insulin Resistance Diet combined to Alzheimer's disease Sweet corn releases antioxidants on cooking

(Date:12/4/2009)FREMONT, Calif., Dec. 4 Vermillion, Inc. (VRML) (Pink Sheets: VRMLQ) announced that on December 3, 2009, it filed its First Amended Plan of Reorganization and related amended Disclosure Statement wit

(Date:12/4/2009)OMAHA, Neb., Dec. 4 Amber Pharmacy announced today that it received accreditation by the Accreditation Commission for Health Care, Inc. (ACHC) for specialized pharmacy services. For nearly 15 years,

(Date:12/4/2009)DURHAM, N.C., Dec. 4 Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced that the first patient has been enrolled in the company,s Phase II-b, dose escalation, clinical trial in S

Breaking Medicine Technology:Vermillion Files Amended Plan of Reorganization and Exchanges Debt 2 Vermillion Files Amended Plan of Reorganization and Exchanges Debt 3 Amber Pharmacy Earns Accreditation From ACHC 2 Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2 Judge Halts IHSS Home Care Cuts 3B Says They Likely Violate Federal Law 59781 1 Judge Halts IHSS Home Care Cuts 3B Says They Likely Violate Federal Law 59781 2 Narconon of Georgia Applauds Efforts of Prescription Buy Back Programs 5577 1 Narconon of Georgia Applauds Efforts of Prescription Buy Back Programs 5577 2 Researcher honored for experimental work in nanotechnology 14533 1 Researcher honored for experimental work in nanotechnology 14533 2

[0] Vermillion Files Amended Plan of Reorganization and Exchanges Debt [0] Amber Pharmacy Earns Accreditation From ACHC [0] Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland

... April 11, 2007 (PRIME NEWSWIRE) --,Hana Bioscienc...sed,on advancing cancer care, will present preclin...ion at the American Association,for Cancer Researc...geles, California. , Abstract No. 2210: "Combining...mall cell lung cancer (NSCLC) athymic nude,mice xe...

...onex Inc. (TSX:LPX), a,biopharmaceutical company s...d to High Density Lipoprotein (HDL), often called,...om further,analysis of the Phase I/II Clinical Tri...ped for the treatment of dyslipidemia and,heart di...indicated that all,blood chemistry and blood press...

Other Medicine Technology:Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 2 Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 3 Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical,Trial Data 2 Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical,Trial Data 3

Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical,Trial Data

... Clear Plus™ Uncuffed Endotracheal Tube w. F...et inside. Sterile, Single use. A quality Rusch en... is ready to use saving you time and storage space...ate smooth withdrawal. It is designed with a soft ...

Slick Set® Uncuffed

Cuffed Nasoral Magill

...ubber tube with Murphy eye. Laser resistant foam s...uffs (One inside other) 40cm (16") long, Single Us...access and optimum visibility within the operating...he tube shaft has a special laser-guard of approx....

Medicine Products:

Uncuffed Nasoral Murphy With Stylet Slick Set® Uncuffed Cuffed Nasoral Magill Cuffed Oral Murphy Laser-Resistant

Westaim announces 2007 year-end results(Months Ended Twelve Months Ended ...),Health